Jinyi Xu Selected Research

Thrombosis (Thrombus)

8/2014	Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents.
4/2013	Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents.
12/2012	Studies on the enantiomers of ZJM-289: synthesis and biological evaluation of antiplatelet, antithrombotic and neuroprotective activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinyi Xu Research Topics

Disease

44	Neoplasms (Cancer) 10/2022 - 03/2007
7	Liver Neoplasms (Liver Cancer) 04/2021 - 05/2017
5	Ischemic Stroke 06/2016 - 12/2012
4	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 01/2021
4	Hypertension (High Blood Pressure) 03/2021 - 09/2007
4	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2019 - 10/2018
3	Thrombosis (Thrombus) 08/2014 - 12/2012
2	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2019
2	Triple Negative Breast Neoplasms 12/2021 - 01/2020
2	Human Influenza (Influenza) 04/2021 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 06/2016 - 12/2012
2	Experimental Melanoma 11/2013 - 07/2012
1	Bacterial Infections (Bacterial Infection) 11/2021
1	Amnesia (Dissociative Amnesia) 10/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Cysts 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Amyloid Plaque 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2019
1	Pathologic Processes 05/2019
1	Hypercholesterolemia 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 02/2018
1	Leukemia 02/2018

Drug/Important Bio-Agent (IBA)

13	oridoninIBA 01/2020 - 08/2008
12	Pharmaceutical PreparationsIBA 11/2021 - 12/2012
6	Biological ProductsIBA 10/2020 - 06/2012
5	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 03/2007
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014 - 03/2007
4	TubulinIBA 04/2021 - 09/2018
4	3-n-butylphthalide (butylphthalide)IBA 06/2016 - 12/2012
3	ProdrugsIBA 10/2022 - 05/2017
3	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 01/2019
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 02/2020 - 06/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020 - 06/2012
3	piperlongumineIBA 01/2020 - 09/2017
3	EstersIBA 06/2019 - 03/2007
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2022 - 01/2021
2	Donepezil (Aricept)FDA LinkGeneric 05/2022 - 01/2021
2	AcidsIBA 10/2021 - 03/2007
2	Peptides (Polypeptides)IBA 01/2021 - 09/2007
2	EnzymesIBA 01/2021 - 05/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2018
2	tetramethylpyrazineIBA 01/2020 - 01/2018
2	23-hydroxybetulinic acidIBA 11/2019 - 10/2015
2	oxidized low density lipoproteinIBA 01/2019 - 01/2013
2	AntioxidantsIBA 10/2018 - 06/2016
2	DiterpenesIBA 02/2018 - 01/2013
2	elemeneIBA 07/2017 - 07/2017
2	1H-tetrazole (tetrazole)IBA 07/2012 - 09/2007
1	SulfonesIBA 05/2022
1	Neuroprotective AgentsIBA 05/2022
1	AcetylcholinesteraseIBA 05/2022
1	evodiamineIBA 12/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	UreaseIBA 11/2021
1	acetohydroxamic acid (Lithostat)FDA Link 11/2021
1	PeroxidesIBA 10/2021
1	GlyceraldehydeIBA 10/2021
1	PyrimidinonesIBA 10/2021
1	Tacrine (Cognex)FDA Link 10/2021
1	tau Proteins (tau Protein)IBA 10/2021
1	Scopolamine (Hyoscine)FDA Link 10/2021
1	Neuraminidase (Sialidase)IBA 04/2021
1	Oseltamivir (Tamiflu)FDA Link 04/2021
1	Phosphates (Orthophosphate)IBA 04/2021
1	Delayed-Action PreparationsIBA 03/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Proteolysis Targeting ChimeraIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	alectinibIBA 01/2021
1	cytoplasmic protein A (PACD)IBA 01/2021
1	Small Untranslated RNAIBA 01/2021
1	deguelinIBA 10/2020
1	Nitric Oxide DonorsIBA 10/2020
1	Carbon MonoxideIBA 02/2020
1	GasotransmittersIBA 02/2020
1	IntegrinsIBA 01/2020
1	HAO472IBA 01/2020
1	NitratesIBA 02/2019
1	fosbretabulin (combretastatin A4)IBA 02/2019
1	LDL CholesterolIBA 01/2019
1	naftopidilIBA 01/2019
1	SaltsIBA 01/2019
1	Colchicine FDA LinkGeneric 09/2018
1	divinyl sulfoneIBA 09/2018
1	enmeinIBA 02/2018
1	Cytochromes c (Cytochrome c)IBA 02/2018

Therapy/Procedure

14	Therapeutics 10/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 07/2017 - 09/2015
1	Telescopes 01/2021
1	Intravenous Injections 01/2019
1	Immunotherapy 01/2019